Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Levobupivacaine for Pain Relief After Esophageal ESD
NCT06611176Recruiting
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of levobupivacaine in postprocedural pain (CPSP) (2 arms). Primary endpoint: Pain scores based on a 0-10 Numeric Rating Scale. Started Oct 2024; status: recruiting.
02
Drugs
levobupivacaine
03
Conditions
postprocedural pain (CPSP)
Beyond the preview
Go deeper on NCT06611176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06611176.